Israel’s NeuroSense Therapeutics is developing a treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. It is based on a discovery by Weizmann Institute Professor Eran Hornstein of a micro-RNA molecule lacking in the muscles of ALS patients.
http://www.globes.co.il/en/article-neurosense-to-develop-als-treatment-1001180069